Pilot study of oral administration of a curcumin-phospholipid formulation for treatment of central serous chorioretinopathy

References

• GraefeAVUber centrale recidivierende retinitisGraefes Arch Clin Exp Ophthalmol186612211215 [German]
   Google Scholar
• GassJDPathogenesis of disciform detachment of the neuroepitheliumAm J Ophthalmol196763Suppl 311396019308
   PubMedGoogle Scholar
• MohanRSivakJAshtonPCurcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase BJ Biol Chem200027514104051041210744729
   PubMed Web of Science ®Google Scholar
• ChenMHuDNPanZLuCWXueCYAassICurcumin protects against hyperosmoticity-induced IL-1 beta elevation in human corneal epithelial cell via MAPK pathwaysExp Eye Res201090343744320026325
   PubMed Web of Science ®Google Scholar
• BengmarkSCurcumin, an atoxic antioxidant and natural NF kappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseasesJPEN J Parenter Enteral Nutr2006301455116387899
   PubMed Web of Science ®Google Scholar
• BrightJJCurcumin and autoimmune diseaseAdv Exp Med Biol200759542545117569223
   PubMed Web of Science ®Google Scholar
• JacobAWuRZhouMWangPMechanism of the anti-inflammatory effect of curcumin: PPAR-gamma activationPPAR Res200720078936918274631
   PubMed Web of Science ®Google Scholar
• NonnLDuongDPeehlDMChemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cellsCarcinogenesis20072861188119617151092
   PubMed Web of Science ®Google Scholar
• ShakibaeiMJohnTSchulze-TanzilGLehmannIMobasheriASuppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritisBiochem Pharmacol20077391434144517291458
   PubMed Web of Science ®Google Scholar
• StrimpakosASSharmaRACurcumin: preventive and therapeutic properties in laboratory studies and clinical trialsAntioxid Redox Signal200810351154518370854
   PubMed Web of Science ®Google Scholar
• HoltPRKatzSKirshoffRCurcumin therapy in inflammatory bowel disease: a pilot studyDig Dis Sci200550112191219316240238
   PubMed Web of Science ®Google Scholar
• JobinCBradhamCARussoMPCurcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activityJ Immunol199916363474348310477620
   PubMed Web of Science ®Google Scholar
• GoelAKunnumakkaraABAggarwalBBCurcumin as “curecumin”: from kitchen to clinicBiochem Pharmacol200875478780917900536
   PubMed Web of Science ®Google Scholar
• BiswasSRahmanIModulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcuminMol Nutr Food Res200852998799418327875
   PubMed Web of Science ®Google Scholar
• YadavVSMishraKPSinghDPMehrotraSSinghVKImmunomodulatory effects of curcuminImmunopharmacol Immunotoxicol200527348549716237958
   PubMed Web of Science ®Google Scholar
• KumarPASuryanarayanaPReddyPYReddyGBModulation of alpha-crystallin chaperone activity in diabetic rat lens by curcuminMol Vis20051156156816088325
   PubMed Web of Science ®Google Scholar
• Malchiodi-AlbediFMatteucciABernardoAMinghettiLPPAR-gamma, microglial cells, and ocular inflammation: new venues for potential therapeutic approachesPPAR Res2008200829578418382616
   PubMed Web of Science ®Google Scholar
• MurataTHeSHangaiMPeroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularizationInvest Ophthalmol Vis Sci20004182309231710892878
   PubMed Web of Science ®Google Scholar
• BonneCPPAR gamma: a novel pharmacological target against retinal and choroidal neovascularizationJ Fr Ophtalmol2005283326330 French15883500
   PubMed Web of Science ®Google Scholar
• SiddiquiAMCuiXWuRThe anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gammaCrit Care Med20063471874188216715036
   PubMed Web of Science ®Google Scholar
• JiangCTingATSeedBPPAR-gamma agonists inhibit production of monocyte inflammatory cytokinesNature1998391666282869422509
   PubMed Web of Science ®Google Scholar
• IijimaHIidaTMurayamaKImaiMGohdoTPlasminogen activator inhibitor 1 in central serous chorioretinopathyAm J Ophthalmol1999127447747810218712
   PubMed Web of Science ®Google Scholar
• CaccavaleAImparatoMRomanazziFNegriAPortaAFerentiniFA new strategy of treatment with low-dosage acetyl salicylic acid in patients affected by central serous chorioretinopathyMed Hypotheses200973343543719427737
   PubMed Web of Science ®Google Scholar
• CuomoJAppendinoGDernASComparative absorption of a standardized curcuminoid mixture and its lecithin formulationJ Nat Prod201174466466921413691
   PubMed Web of Science ®Google Scholar
• AnandPKunnumakkaraABNewmanRAAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm20074680781817999464
   PubMed Web of Science ®Google Scholar
• WangYJPanMHChengALStability of curcumin in buffer solutions and characterization of its degradation productsJ Pharm Biomed Anal19971512186718769278892
   PubMed Web of Science ®Google Scholar
• MarczyloTHVerschoyleRDCookeDNMorazzoniPStewardWPGescherAJComparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholineCancer Chemother Pharmacol200760217117717051370
   PubMed Web of Science ®Google Scholar
• MarczyloTHStewardWPGescherAJRapid analysis of curcumin and curcumin metabolites in rat biomatrices using a novel ultraperformance liquid chromatography (UPLC) methodJ Agric Food Chem200957379780319152267
   PubMed Web of Science ®Google Scholar
• CaccavaleARomanazziFImparatoMNegriAMoranoAFerentiniFCentral serous chorioretinopathy: a pathogenetic modelClin Ophthalmol2011523924321386917
   PubMedGoogle Scholar
• ChenLYangPKijlstraADistribution, markers, and functions of retinal microgliaOcul Immunol Inflamm2002101273912461701
   PubMed Web of Science ®Google Scholar
• LiLBraitehFSKurzrockRLiposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesisCancer200510461322133116092118
   PubMed Web of Science ®Google Scholar
• JurenkaJSAnti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical researchAltern Med Rev200914214115319594223
   PubMed Web of Science ®Google Scholar
• LalBKapoorAKAsthanaOPEfficacy of curcumin in the management of chronic anterior uveitisPhytother Res199913431832210404539
   PubMed Web of Science ®Google Scholar
• LalBKapoorAKAgrawalPKAsthanaOPSrimalRCRole of curcumin in idiopathic inflammatory orbital pseudotumoursPhytother Res200014644344710960899
   PubMed Web of Science ®Google Scholar
• SharmaRAStewardWPGescherAJPharmacokinetics and pharmacodynamics of curcuminAdv Exp Med Biol200759545347017569224
   PubMed Web of Science ®Google Scholar
• LaoCDRuffinMTNormolleDDose escalation of a curcuminoid formulationBMC Complement Altern Med200661016545122
   PubMedGoogle Scholar
• BishtSFeldmannGSoniSRaviRKarikarCMaitraAPolymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapyJ Nanobiotechnology20075317439648
   PubMedGoogle Scholar
• MaitiKMukherjeeKGantaitASahaBPMukherjeePKCurcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in ratsInt J Pharm20073301–215516317112692
   PubMed Web of Science ®Google Scholar
• AggarwalBBSungBPharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targetsTrends Pharmacol Sci2009302859419110321
   PubMed Web of Science ®Google Scholar
• BarryJFritzMBrenderJRSmithPELeeDKRamamoorthyADetermining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcuminJ Am Chem Soc2009131124490449819256547
   PubMed Web of Science ®Google Scholar
• AggarwalBBHarikumarKBPotential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseasesInt J Biochem Cell Biol2009411405918662800
   PubMed Web of Science ®Google Scholar
• BouzasEAMoretPPournarasCJCentral serous chorioretinopathy complicating solar retinopathy treated with glucocorticoidsGraefes Arch Clin Exp Ophthalmol199923721661689987635
   PubMed Web of Science ®Google Scholar
• WangMMunchICHaslerPWPrunteCLarsenMCentral serous chorioretinopathyActa Ophthalmol200886212614517662099
   PubMed Web of Science ®Google Scholar
• JeongSJKohWLeeEOAntiangiogenic phytochemicals and medicinal herbsPhytother Res201125111020564543
   PubMed Web of Science ®Google Scholar
• ArbiserJLKlauberNRohanRCurcumin is an in vivo inhibitor of angiogenesisMol Med19984637638310780880
   PubMed Web of Science ®Google Scholar
• KowluruRAKanwarMEffects of curcumin on retinal oxidative stress and inflammation in diabetesNutr Metab (Lond)20074817437639
   PubMed Web of Science ®Google Scholar